NCT05252546
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-positive Recurrent / Metastatic Breast Cancer, +4 more
- Locations
-
- Xiangya Hospital Central South University Changsha, Hunan, China
Clinical trial condition
HER2-positive Recurrent / Metastatic Breast Cancer
Explore clinical trials studying HER2-positive Recurrent / Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies